Kiora Pharmaceuticals (KPRX) Assets Average (2016 - 2025)
Kiora Pharmaceuticals (KPRX) has disclosed Assets Average for 11 consecutive years, with $30.9 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Assets Average fell 22.08% year-over-year to $30.9 million, compared with a TTM value of $30.9 million through Sep 2025, down 22.08%, and an annual FY2024 reading of $25.1 million, changed N/A over the prior year.
- Assets Average was $30.9 million for Q3 2025 at Kiora Pharmaceuticals, down from $37.5 million in the prior quarter.
- Across five years, Assets Average topped out at $41.6 million in Q2 2024 and bottomed at $9.1 million in Q3 2021.
- Average Assets Average over 5 years is $22.1 million, with a median of $18.1 million recorded in 2021.
- The sharpest move saw Assets Average soared 153.29% in 2024, then fell 22.08% in 2025.
- Year by year, Assets Average stood at $10.1 million in 2021, then surged by 63.36% to $16.6 million in 2022, then decreased by 10.62% to $14.8 million in 2023, then skyrocketed by 153.29% to $37.5 million in 2024, then fell by 17.58% to $30.9 million in 2025.
- Business Quant data shows Assets Average for KPRX at $30.9 million in Q3 2025, $37.5 million in Q4 2024, and $39.7 million in Q3 2024.